<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The <z:chebi fb="0" ids="16856">glutathione</z:chebi> S-transferases (GST) mediate exposure to various cytotoxic and <z:chebi fb="0" ids="50902">genotoxic agents</z:chebi>, including those associated with increased risk of the <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Both GST M1 (GSTM1) and GST theta 1 (GSTT1) genes have a "null" variant allele, in which the entire gene is absent </plain></SENT>
<SENT sid="2" pm="."><plain>We tested whether the homozygous null genotype of GSTM1 and GSTT1 altered the risk for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: In a hospital-based case-control study we analysed lymphocyte or bone-marrow DNA samples from 96 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and 201 cancer-free controls of similar age, race, and sex </plain></SENT>
<SENT sid="4" pm="."><plain>We have restricted our report to the 92 white <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
<SENT sid="5" pm="."><plain>We analysed GSTM1 and GSTT1 genotypes by PCR </plain></SENT>
<SENT sid="6" pm="."><plain>FINDINGS: The frequency of the GSTT1 null genotype was higher among <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cases (46%) than among controls (16%) </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000005'>Inheritance</z:hpo> of the GSTT1 null genotype conferred a 4.3-fold of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (odds ratio 4.3, 95% CI 2.5-7.4, p &lt; 0.00001) </plain></SENT>
<SENT sid="8" pm="."><plain>The GSTM1 null genotype was not associated with increased risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (odds ratio 0.8, 0.5-1.3) </plain></SENT>
<SENT sid="9" pm="."><plain>INTERPRETATION: Individuals with the GSTT1 null genotype may have enhanced susceptibility to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>The mechanism might involve decreased detoxification of environmental or endogenous carcinogens </plain></SENT>
</text></document>